The Federal Reserve's Chair Jerome Powell's term is expiring on May 15, 2026.

Cognizant Technology Solutions Corporation (CTSH) Q4 2025 Earnings Call Transcript

Prudential Financial, Inc. (PRU) Q4 2025 Earnings Call Transcript

Bunge Global SA (BG) Q4 2025 Earnings Call Transcript

Orion Group Holdings, Inc. (ORN) M&A Call Transcript

Amid a strong year for the industrials sector, U.S. machinery giant Caterpillar NYSE: CAT was among the most notable standouts of 2025. Using the Industrial Select Sector SPDR Fund NYSEARCA: XLI as a proxy, the sector delivered a total return of around 19% last year.

The Equal Employment Opportunity Commission is investigating allegations that Nike's diversity, equity and inclusion objectives resulted in “a pattern or practice of disparate treatment against white employees.”

Twin Disc, Incorporated (TWIN) Q2 2026 Earnings Call Transcript

Horace Mann Educators Corporation (HMN) Q4 2025 Earnings Call Transcript

Lear Corporation (LEA) Q4 2025 Earnings Call Transcript

American Assets Trust, Inc. (AAT) Q4 2025 Earnings Call Transcript

Oaktree Specialty Lending Corporation (OCSL) Q1 2026 Earnings Call Transcript

GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript

LAS VEGAS, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Toll Brothers Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the grand opening of three highly anticipated model homes at Glenrock, its newest luxury home community in Las Vegas. Located in the sought-after Summerlin master plan, Glenrock is a gated enclave of stunning single-family homes designed to redefine modern living.

With stocks once more swimming in red ink amid another tech sector rotation , options traders are starting to jump ship.

Altria Group regains Buy rating after the release of its Q4 2025 and full year 2025 results, owing crucially to clarity on future earnings and dividends. The company expects continued growth in adjusted diluted EPS and in dividends until 2028, which is important considering its lucrative dividends. Hope of progress on its tobacco free products is encouraging too, even as its forward P/E is less compelling.

The “indiscriminate” chip selloff is reminiscent of DeepSeek fears that were “proved unfounded,” a Bank of America analyst said.

Eli Lilly and Company defies valuation skeptics, posting 45% revenue growth and 96% EPS growth in 2025, with 2026 guidance projecting $80–83 billion in revenue and $33.5–35 EPS. LLY's manufacturing investments and pipeline strength, especially tirzepatide and retatrutide, position it to outpace Novo Nordisk A/S in the GLP-1/obesity market. NVO faces 2026 revenue and profit declines due to U.S. pricing pressures, patent expiries, and manufacturing disadvantages despite a strong dividend yield.

The classic refrain of "buy the dip" may sound like a siren song.

The cannabis industry is in another pivotal time where consistent changes are being made. Laws and regulations have been passed across the country that have aided in the further development of industry. For most marijuana stock investors, this is the area where shareholders tend to focus. Investors know that a company is doing well, or is working towards a significant goal, which can all lead to profitability. There are different sectors and markets to pay attention to.